MEDICAMEN BIOTECH
|
The Current P/E Ratio of MEDICAMEN BIOTECH is 80.39.
Share Price | ₹383.6 | Jul 29,2025 |
Market Cap | ₹521.6 Cr | |
Earnings-TTM | ₹6.5 Cr | TTM-Consolidated Results |
Price/Earnings | 80.39x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of MEDICAMEN BIOTECH
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹521.6 Cr] as on Jul 29,2025
(/) Earnings [ ₹6.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 80.39x ]
Thus, for MEDICAMEN BIOTECH , the investors are currently willing to pay 80.39 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of MEDICAMEN BIOTECH !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of MEDICAMEN BIOTECH over the last five years.
Historical PE (Price/Earnings) ratio chart of MEDICAMEN BIOTECH
PE Ratio Performance Analysis for MEDICAMEN BIOTECH
- MEDICAMEN BIOTECH 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 46.16x.
- MEDICAMEN BIOTECH 's operated at median p/e ratio of 52.79x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, MEDICAMEN BIOTECH 's p/e ratio peaked in Mar2023 at 56.31x.
- MEDICAMEN BIOTECH 's p/e ratio hit its five-year low in Mar2020 of 16.61x.
How does MEDICAMEN BIOTECH 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
MEDICAMEN BIOTECH | 6.49 | 80.39 | 521.6 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 37.38 | 410,466.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 80.92 | 177,298.0 |
CIPLA LTD | 5,406.81 | 23.51 | 127,140.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 63.71 | 127,538.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.95 | 108,500.0 |
MANKIND PHARMA LTD | 2,003.22 | 52.60 | 105,363.0 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 21.69 | 100,095.0 |
LUPIN LTD | 3,306.26 | 27.41 | 90,634.7 |
AUROBINDO PHARMA LTD | 3,515.26 | 19.13 | 67,262.6 |
ABBOTT INDIA LTD | 1,414.44 | 52.18 | 73,812.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs MEDICAMEN BIOTECH 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.95x |
Max industry PE | 80.92x |
Median industry PE | 37.38x |
Average industry PE | 43.44x |
You may also like the below Video Courses